Brief: Astrazeneca Pharma India June-Qtr Loss After Tax 117.9 Mln Rupees
08/08/2024 10:17
Aug 8 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* JUNE-QUARTER LOSS AFTER TAX 117.9 MILLION RUPEES
* JUNE-QUARTER REVENUE FROM OPERATIONS 3.88 BILLION RUPEES
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan